Key facts
- This page summarizes Bruce Car's Form 4 filing for Biohaven Ltd. (BHVN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2026, 18:07.
Bruce Car - 27 Feb 2026 Form 4 Insider Report for Biohaven Ltd. (BHVN)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- BHVN
- Reported as of
- 27 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 18:07:42 UTC
- Prior SEC filing
- 07 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ George Clark, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bruce Car filed Form 4 for Biohaven Ltd. (BHVN) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 07 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001798876
Primary reporting owner
Car Bruce
- Relationship
- Chief Scientific Officer
- Address
- C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN
- Signature
- /s/ George Clark, Attorney-in-Fact
- Signature date
- 03 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BHVN
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +175,000
- Change %
- Price
- $0.000000
- Shares after
- 175,000
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 175,000
- Exercise price
- $11.52
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date.